concept

PROTEIN AGGREGATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PROTEIN AGGREGATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

635Connections

0Hypotheses

4Analyses

50Outgoing

50Incoming

0Experiments

4Debates

Summary

PROTEIN AGGREGATION is a concept in neurodegeneration research. Key relationships include: associated with, co discussed, regulates. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 49 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	PROTEIN AGGREGATION
Key Genes/Proteins	AKT, ALPHA-SYNUCLEIN, AMYLOID, APP, CGAS, CTSD
Related Diseases	AGING, ALS, ALZHEIMER, APOPTOSIS, CERAMIDE

Wiki Pages (1)

Knowledge base pages for this entity

Protein Aggregation in Neurodegeneration

mechanism · 2428 words

Pathway Diagram

graph TD
    PROTEIN_AGGREGATION["PROTEIN AGGREGATION"]
    PROTEIN_AGGREGATION -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    PROTEIN_AGGREGATION -->|"activates"| Neuroinflammation["Neuroinflammation"]
    Autophagy_lysosomal_pathway["Autophagy-lysosomal pathway"] -.protects against.-> PROTEIN_AGGREGATION
    autophagy_lysosomal_pathway["autophagy-lysosomal pathway"] -.protects against.-> PROTEIN_AGGREGATION
    autophagy["autophagy"] -.protects against.-> PROTEIN_AGGREGATION
    Neuroinflammation -->|"activates"| PROTEIN_AGGREGATION
    CERS2["CERS2"] -->|"inhibits"| PROTEIN_AGGREGATION
    CHMP2A["CHMP2A"] -->|"activates"| PROTEIN_AGGREGATION
    CHMP2B["CHMP2B"] -->|"activates"| PROTEIN_AGGREGATION
    CHMP6["CHMP6"] -->|"activates"| PROTEIN_AGGREGATION
    COMPLEMENT["COMPLEMENT"] -->|"expressed in"| PROTEIN_AGGREGATION
    PTN["PTN"] -->|"expressed in"| PROTEIN_AGGREGATION

Outgoing (86)

Target	Relation	Type	Str
Neurodegenerative Diseases	causes	disease	0.95
Neurodegeneration	associated_with	disease	0.95
Amyloid	associated_with	protein	0.95
neurodegenerative diseases	contributes_to	disease	0.95
neurodegeneration	causes	process	0.95
Alzheimer's Disease	causes	disease	0.95
Neurodegenerative Diseases	associated_with	disease	0.92
SOLUBLE OLIGOMERS	associated_with	protein	0.90
neurodegeneration	mediates	phenotype	0.90
Neuroplasticity	associated_with	process	0.90
Neurodegenerative Disease	causes	disease	0.90
Alzheimer's Disease	contributes_to	disease	0.90
Huntington's Disease	causes	disease	0.90
Neuroinflammation	causes	process	0.90
Alzheimer's Disease	causes	disease	0.90
Neuronal Degeneration	contributes_to	process	0.90
Parkinson's Disease	causes	disease	0.90
Alzheimer's Disease	mediates	disease	0.90
Tau	involved_in	protein	0.90
Amyloid-Beta	involved_in	protein	0.90
Neurodegeneration	causes	process	0.85
detergent-insoluble proteome	contributes_to	process	0.85
ALZHEIMER'S DISEASE	causes	disease	0.85
Alzheimer's Disease	contributes_to	disease	0.85
Amyotrophic Lateral Sclerosis	biomarker_for	disease	0.85
pathological spreading	causes (protein aggregation drives cell-to-cell spreading )	mechanism	0.85
geographic atrophy	promotes	phenotype	0.80
Amyotrophic Lateral Sclerosis	causes	disease	0.75
inflammation	promotes	process	0.70
Neuroinflammation	activates	process	0.70
neuronal loss	promotes	process	0.70
Alzheimer's disease	causes	disease	0.70
SENESCENCE	interacts_with	phenotype	0.65
SNCA	activates	gene	0.60
PROTEOSTASIS	targets	phenotype	0.60
Proteins	inhibits	protein	0.50
Proteins	interacts_with	protein	0.50
NUCLEUS	interacts_with	concept	0.50
NEURODEGENERATIVE DISEASE	associated_with	concept	0.50
ALZHEIMER'S	activates	concept	0.50
HUNTINGTON'S	activates	concept	0.50
NICOTINAMIDE	associated_with	drug	0.50
Neuron	associated_with	cell_type	0.50
MITOCHONDRIAL DYSFUNCTION	associated_with	process	0.50
MITOCHONDRIAL DYSFUNCTION	activates	process	0.50
ALZHEIMER'S	associated_with	concept	0.50
FRONTOTEMPORAL	associated_with	concept	0.50
PARKINSON'S	activates	concept	0.50
SYNUCLEIN	activates	concept	0.50
α-SYNUCLEIN	activates	concept	0.50

Incoming (549)

Source	Relation	Type	Str
RNA G-quadruplexes	mediates	process	0.95
Tardbp	promotes	protein	0.92
HNRNPA2B1	contributes_to	protein	0.92
SNCA	involved_in	protein	0.90
amyloid-beta peptide	promotes	compound	0.90
Parkin	regulates	protein	0.90
HTT	promotes	gene	0.90
SQSTM1	regulates	gene	0.90
HSP90	suppresses	protein	0.90
tau	promotes	protein	0.90
TARDBP	associated_with	protein	0.90
Neurodegeneration-Associated Proteins Accumulation	promotes	phenotype	0.90
TAU	associated_with	protein	0.90
PRKAA2	regulates	gene	0.90
Amyloid-Beta	involved_in	protein	0.90
Tdp-43	drives	protein	0.90
Neuroinflammation	upregulates	process	0.90
phase separation	drives	process	0.90
AMYOTROPHIC LATERAL SCLEROSIS	associated_with	gene	0.90
40624017	induces	paper	0.90
Autophagy	associated_with	process	0.90
Intrinsically Disordered Low-Complexity Domain	contributes_to	mechanism	0.90
Molecular Chaperones	suppresses	protein	0.90
Intra-Condensate Demixing	mediates	process	0.90
DNAJB6	inhibits	protein	0.90
Proteostasis Disruption	causes	process	0.90
HSPB8	modulates	protein	0.88
Inflammasome	associated_with	pathway	0.88
SQSTM1	prevents	protein	0.87
protein over-synthesis	promotes	process	0.85
intrinsically disordered domain	promotes	phenotype	0.85
chaperone-mediated autophagy	suppresses	process	0.85
HSP27	suppresses	protein	0.85
Cytoskeletal Disruption	promotes	process	0.85
Proteostasis Network	regulates	pathway	0.85
Protein Clearance Enhancement	suppresses	pathway	0.85
Tardbp	drives	protein	0.85
Endoplasmic Reticulum Dysfunction	contributes_to	process	0.85
super-resolution microscopy	involved_in	process	0.85
protein oligomers	involved_in	protein	0.85
LGMDD1	associated_with	disease	0.85
HSPB8 FRAMESHIFT MUTANT	contributes_to	protein	0.85
Autophagy	suppresses	process	0.85
P62	biomarker_for	protein	0.85
Environmental Stress	promotes	process	0.85
APOE	modulates	protein	0.80
stress granule dynamics	contributes_to	process	0.80
chromium	promotes	compound	0.80
HUNTINGTON	implicated_in	disease	0.80
METFORMIN	inhibits	drug	0.80

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (4)

Scientific analyses that reference this entity

Is ferroptosis the primary driver of motor neuron death in ALS or an epiphenomen

neurodegeneration | 2026-04-18 | 4 hypotheses Top: 0.538

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

neurodegeneration | 2026-04-08 | 0 hypotheses

How do host cell factors influence the conformation and propagation properties o

neurodegeneration | 2026-04-08 | 0 hypotheses

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.803

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (4)

Multi-agent debates referencing this entity

The debate highlighted compelling correlative evidence for ferroptosis markers i

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

How do host cell factors influence the conformation and propagation properties o

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

closed · Rounds: 4 · Score: 0.94 · 2026-04-10

Evaluate the potential of CRISPR/Cas9 and related gene editing technologies for

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Related Research

Hypotheses and analyses mentioning PROTEIN AGGREGATION in their description or question text

No additional research found